These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2249019)

  • 21. Methotrexate-paclitaxel-epirubicin-carboplatin (M-TEC) combination chemotherapy in patients with advanced bladder cancer: an open label phase II study.
    Tsavaris N; Kosmas C; Skopelitis H; Dimitrakopoulos A; Kopterides P; Bougas D; Stravodimos K; Mitropoulos D; Alamanis C; Giannopoulos A
    J Chemother; 2005 Aug; 17(4):441-8. PubMed ID: 16167525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.
    Bramwell VH; Morris D; Ernst DS; Hings I; Blackstein M; Venner PM; Ette EI; Harding MW; Waxman A; Demetri GD
    Clin Cancer Res; 2002 Feb; 8(2):383-93. PubMed ID: 11839653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: a preliminary report on safety.
    Catimel G; Spielmann M; Dieras V; Kayitalire L; Pouillart P; Guastalla JP; Soler-Michel P; Graffand N; Garet F; Dumortier A; Pellae-Cosset B; Chazard M
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):24-7. PubMed ID: 8629032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential administration of epirubicin and paclitaxel for advanced breast cancer. A phase I randomised trial.
    Focan C; Graas MP; Beauduin M; Canon JL; Salmon JP; Jerusalem G; Focan-Henrard D; Lobelle JP; Schallier D
    Anticancer Res; 2005; 25(2B):1211-7. PubMed ID: 15865068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-agent ifosfamide in the treatment of anthracycline-refractory adult sarcomas.
    Lopez M; Carpano S; Amodio A; Gionfra T; Della Giulia M; Foggi P; Manfredi C; Del Monte G
    Clin Ter; 1998; 149(5):331-3. PubMed ID: 10052244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epirubicin high-dose therapy in advanced breast cancer: preliminary clinical data. Epirubicin as a single agent in breast cancer.
    Neri B; Pacini P; Bartalucci S; Moroni F; Menchi I; Cappellini M
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):388-91. PubMed ID: 2793274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of Baker's antifol in metastatic sarcoma.
    Thigpen JT; O'Bryan RM; Benjamin RS; Coltman CA
    Cancer Treat Rep; 1977 Nov; 61(8):1485-7. PubMed ID: 922752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group Study.
    Samson MK; Baker LH; Benjamin RS; Lane M; Plager C
    Cancer Treat Rep; 1979; 63(11-12):2027-9. PubMed ID: 575067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epirubicin and DTIC (EDIC) for advanced soft-tissue sarcomas.
    Lopez M; Carpano S; Di Lauro L; Vici P; Conti EM
    Oncology; 1991; 48(3):230-3. PubMed ID: 2023703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group.
    Mouridsen HT; Bastholt L; Somers R; Santoro A; Bramwell V; Mulder JH; van Oosterom AT; Buesa J; Pinedo HM; Thomas D
    Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1477-83. PubMed ID: 3479329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma.
    Jelić S; Kovcin V; Milanović N; Babović N; Kreacić M; Ristović Z; Vlajić M; Filipović-Ljesković I
    Eur J Cancer; 1997 Feb; 33(2):220-5. PubMed ID: 9135492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma.
    Jelić S; Vuletić L; Milanović N; Tomasević Z; Kovcin V
    Tumori; 1990 Oct; 76(5):467-71. PubMed ID: 2256192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fotemustine: a pilot phase II trial in sarcoma of the soft tissues].
    Spielmann M; Berille J; Khayat D; Bizzari JP; Jacquillat C; Tursz T
    Bull Cancer; 1991; 78(5):453-6. PubMed ID: 1878607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing single epirubicin doses in advanced soft tissue sarcomas.
    Lopez M; Vici P; Di Lauro L; Carpano S
    J Clin Oncol; 2002 Mar; 20(5):1329-34. PubMed ID: 11870176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.
    Nielsen OS; Dombernowsky P; Mouridsen H; Crowther D; Verweij J; Buesa J; Steward W; Daugaard S; van Glabbeke M; Kirkpatrick A; Tursz T
    Br J Cancer; 1998 Dec; 78(12):1634-9. PubMed ID: 9862576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidoxorubicin plus ifosfamide in advanced and/or metastatic soft-tissue sarcomas.
    Toma S; Coialbu T; Biassoni L; Folco U; Gatti C; Canavese G; Giacchero A; Rosso R
    Cancer Chemother Pharmacol; 1990; 26(6):453-6. PubMed ID: 2121378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-(phosphonacetyl)-L-aspartate (PALA) in advanced soft tissue sarcoma: a phase II trial of the EORTC soft tissue sarcoma group.
    Bramwell V; Van Oosterom A; Mouridsen HT; Cheix F; Somers R; Thomas D; Rozencweig M
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):81-4. PubMed ID: 6211362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas.
    Bokemeyer C; Harstrick A; Schmoll HJ; Köhne-Wömpner CH; Schöffski P; Poliwoda H
    Ann Oncol; 1992 Jun; 3(6):487-8. PubMed ID: 1498067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose epirubicin for untreated patients with advanced tumours: a phase I study.
    Martoni A; Melotti B; Guaraldi M; Pacciarini MA; Riva A; Pannuti F
    Eur J Cancer; 1990; 26(11-12):1137-40. PubMed ID: 1963544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.